Mumbai: Given that the "pandemic" of cardiovascular diseases (CVD) accounts for more than 25% of yearly fatalities in India, it has become crucial to increase public understanding regarding cardiac wellness and methods to control the critical risk element—low-density lipoprotein cholesterol (LDL-C).
The central idea for an event called 'Beat Bad Cholesterol,' organized by leading international pharmaceutical company Novartis and The Times of India, was this theme.
Cardiologists caution that high levels of harmful cholesterol (LDL-C) can go unnoticed until they result in a severe incident such as a heart attack. Dr. Amitabh Dube, country president and managing director at Novartis India, stated, “Cardiovascular diseases remain among the top causes of death in India. There’s still inadequate awareness regarding crucial risk elements like LDL-C.” He further mentioned that their 'Beat Bad Cholesterol' initiative aims to motivate individuals to check their vital statistics and collaborate with healthcare providers for better cardiovascular care.
According to a 2023 study in The Lancet, individuals from India face a greater load of cardiovascular diseases (CVDs), experience these conditions at younger ages, encounter higher mortality rates, and suffer more premature fatalities. Early identification and prompt medical action can be achieved solely through routine lipid profile tests since high levels of low-density lipoprotein cholesterol (LDL-C) do not exhibit noticeable signs.
At the event, Judith Love, who serves as the president of APMA Region at Novartis, highlighted that elevated levels of low-density lipoprotein cholesterol (LDL-C) pose a hidden danger, frequently ignored until it becomes critical. She emphasized, “Through appropriate awareness, education, and timely interventions, we have the potential to alter this course. Programs such as these underscore our shared dedication.”
She stated, "Every one of us carries the duty to set an example by making healthy decisions that safeguard our cardiovascular health. The magnitude, skills, and enthusiasm present here in India provide us with a robust stage to create enduring change."
Dr. Nikhil Parchure, a senior cardiologist at Apollo Hospitals, offered his medical viewpoint on the dangers associated with low-density lipoprotein cholesterol (LDL-C). Ram Khandelwal, who founded the Heart Health India Foundation—a platform aimed at supporting both patients and their caretakers—highlighted the significance of adopting healthier lifestyles. Additionally, Rajeev Nivatkar, the Maharashtra Commissioner responsible for Medical Education and AYUSH, discussed various preventative health initiatives taken by the government. The event saw active participation from an array of attendees including healthcare experts, governmental representatives, and leading figures within the media sector. They all engaged in a physical activity session led by renowned fitness trainer Aanchal Hans.
Mumbai: Given that the "pandemic" of cardiovascular diseases (CVD) accounts for more than 25% of yearly fatalities in India, it has become crucial to increase public knowledge regarding cardiac well-being and methods to control the critical risk element—low-density lipoprotein cholesterol (LDL-C).
The central topic at a recent event called 'Beat Bad Cholesterol,' organized by leading global pharmaceutical company Novartis and The Times of India, was this theme.
Cardiologists caution that high levels of harmful cholesterol (LDL-C) can go unnoticed until they lead to severe consequences such as a heart attack or another life-threatening cardiac incident. Dr. Amitabh Dube, who serves as the country president and managing director at Novartis India, stated, “ Cardiovascular diseases remain among the top causes of death in India. There’s still inadequate awareness regarding crucial risk elements like LDL-C.” He further mentioned that under the 'Beat Bad Cholesterol' initiative, individuals will be encouraged to check their vital statistics and collaborate closely with healthcare providers for better cardiovascular care.
According to a 2023 study in The Lancet, people in India face a greater load of cardiovascular diseases (CVDs), with these conditions appearing at younger ages, leading to more fatalities and untimely deaths. Early identification and prompt medical action can be achieved solely through routine checks of their lipid profiles since high levels of low-density lipoprotein cholesterol (LDL-C) do not show noticeable signs.
During the event, Judith Love, who serves as the president of APMA Region at Novartis, highlighted that elevated levels of low-density lipoprotein cholesterol (LDL-C) pose a hidden danger, frequently ignored until it becomes critical. She emphasized, “Through proper awareness, education, and timely interventions, we have the potential to alter this course. Programs such as these underscore our shared dedication.”
She stated, "Every one of us bears the individual duty to set an example by making healthier choices that safeguard our hearts. With India’s magnitude, skills, and enthusiasm, we possess a robust stage to create enduring change."
Dr. Nikhil Parchure, a senior cardiologist at Apollo Hospitals, offered his medical viewpoint on the dangers associated with low-density lipoprotein cholesterol (LDL-C). Ram Khandelwal, who founded the Heart Health India Foundation—a platform designed for patients and caregivers—highlighted the significance of adopting lifestyle changes. Meanwhile, RajeeV Nivatkar, Maharashtra’s Commissioner of Medical Education and AYUSH, discussed the state government's initiatives aimed at promoting preventative health care. The attendees, comprising healthcare providers, governmental representatives, and leading journalists, joined in an exercise routine led by renowned fitness trainer Aanchal Hans.